Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

All content curated by

Shyoko Honiden MD, MSc

Virginia Brady MD

Geoffrey Connors MD, FACP

See All Experts

story of the week

Published in Respiratory Medicine

Journal Scan / Research · July 11, 2024

Efficacy and Safety of Dupilumab in the Treatment of Patients With COPD With Blood Eosinophil Evidence of Type 2 Inflammation

The New England Journal of Medicine

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Sebastian Kurz MD, PhD, FCCP

The New England Journal of Medicine

Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation

N. Engl. J. Med 2024 Jun 27;390(24)2274-2283, SP Bhatt, KF Rabe, NA Hanania, CF Vogelmeier, M Bafadhel, SA Christenson, A Papi, D Singh, E Laws, N Patel, GD Yancopoulos, B Akinlade, J Maloney, X Lu, D Bauer, A Bansal, RM Abdulai, LB Robinson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Efficacy and Safety of Dupilumab in the Treatment of Patients With COPD With Blood Eosinophil Evidence of Type 2 Inflammation

Additional Info

Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation

Further Reading

Efficacy and Safety of Depemokimab in the Treatment of Patients With Severe Asthma With an Eosinophilic Phenotype

Impact of COVID-19 Pandemic on COPD Healthcare Use, Exacerbations, and Mortality

Associations of PRISm and RSP With Risk Factors, Morbidity, and Mortality

Effect of Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine on Exacerbation Rate and Risk in Patients With Moderate to Severe COPD

Prevalence of Critical Errors and Insufficient Peak Inspiratory Flow in Patients Hospitalized With COPD

Impact of Delayed Transition From Noninvasive to Invasive Mechanical Ventilation on Hospital Mortality in Immunocompromised Patients With Sepsis

Role of Biomarker Testing in Guiding Precision Medicine for Patients With Non–Small Cell Lung Cancer

Association Between Naloxone and Clinical Outcomes Among Patients With Out-of-Hospital Cardiac Arrest

Identification, Prevention, and Management of Complications Caused by Devices in the ICU

Safety and Tolerability of Bexotegrast in the Treatment of Patients With IPF

Impact of Age, Frailty, and Multimorbidity on the Effect of ICU Interventions

Recently Updated